Vapocoolant Spray Used Prior to Intravenous (IV) Insertions

• Status: Completed
• Trial end date: 2017-04-28
• Target enrollment: 0
• Participant gender: All

Summary

The primary purpose of this study is to determine if by offering a vapocoolant (cold spray) to hospital outpatients prior to an intravenous catheter (IV) insertion will increase patient satisfaction of IV insertion as well as determine if pain of insertion is decreased.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Aultman Health Foundation
• Treatments: Ethyl Chloride

Criteria

Inclusion Criteria:

• Any outpatient ordered to undergo a Nuclear Medicine Stress Test and is required to have IV access for injection of Radiopharmaceuticals

Exclusion Criteria:

• If it is the first time the patient has had an intravenous catheter inserted

• Any patient who is or may be pregnant

• Any patient who is breast-feeding

• Any patient who has taken a narcotic, sedative and/or anti-anxiety medication within 8 hours of intervention time.

• Any patient who has a known diagnosis of Raynaud's Syndrome or Carpal Tunnel Syndrome.

• Any patient who has an allergy or hypersensitivity to Ethyl Chloride.

• Any patient under the age of 18 and/or any patient over the age of 85

• Any patient who is illiterate

• Any patient who is non-English speaking

• Any patient with prior experience with a vapocoolant spray.